Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Henry N. Ginsberg et al.|European Heart Journal|2017Cited by 3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Željko Reiner, Alberico L. Catapano, Guy De Backer et al.|European Heart Journal|2011Cited by 3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyBørge G. Nordestgaard, Rodrigo da Silva Santos, Gerald F. Watts et al.|European Heart Journal|2013Cited by 2.7k
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G. Nordestgaard, Anne Tybjærg‐Hansen, M. John Chapman et al.|European Heart Journal|2010Cited by 1.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, M. John Chapman et al.|European Heart Journal|2020Cited by 1.5k